Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 23.85
0.00 (0.00%)
Oct 21, 2026, 9:55 AM CST
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 5.8 billion as of October 20, 2026. It is the 21,358th most valuable company in the world and the 1,003rd biggest in Taiwan. Its market cap has decreased by 3.75% in one year.
Market Cap
5.80B
Enterprise Value
5.40B
Revenue
1.52B
Global Rank
Country Rank
#1,003 Taiwan
PE Ratio
24.38
ChartMarket Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 5.80B, an increase of 40.83%. That is a compound annual growth rate of 2.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 5.80B | -0.62% |
| Dec 31, 2025 | 5.83B | -27.36% |
| Dec 31, 2024 | 8.03B | 80.00% |
| Dec 29, 2023 | 4.46B | 14.13% |
| Dec 30, 2022 | 3.91B | 11.76% |
| Dec 30, 2021 | 3.50B | 28.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.15B |
| Standard Chemical & Pharmaceutical | 10.17B |
| SCI Pharmtech | 6.31B |
| Alar Pharmaceuticals | 5.76B |
| Formosa Laboratories | 5.65B |
| Yoda Pharmaceuticals | 4.99B |
| Panion & Bf Biotech | 4.53B |
| LIWANLI Innovation | 4.47B |